Table 3 Main cost-effectiveness results in the seven countries
Strategy | Outcome/country | Argentina | Brazil | Chile | Colombia | Costa Rica | México | Perú |
|---|---|---|---|---|---|---|---|---|
No vaccination | Costs | $ 2,489,103,233 | $ 14,899,414,477 | $ 1,426,693,488 | $ 5,213,429,639 | $ 1,000,387,362 | $ 24,460,665,837 | $ 3,290,563,102 |
QALYs lost* | 1,678,317 | 3,650,818 | 423,399 | 1,878,855 | 130,323 | 4,304,472 | 2,121,919 | |
Deaths | 160,172 | 330,091 | 38,672 | 157,566 | 10,442 | 385,521 | 183,735 | |
Base case (realistic vaccination campaign**) | Costs saved | $ 266,754,782 | $ 4,600,027,570 | ($ 3,167,869) | $ 942,846,561 | $ 374,025,049 | $ 9,689,633,010 | $ 415,853,089 |
QALYs gained* | 737,438 | 1,282,144 | 144,257 | 632,457 | 49,625 | 1,518,053 | 707,797 | |
Deaths avoided | 85,414 | 152,547 | 17,877 | 67,996 | 4,955 | 165,561 | 78,791 | |
Cost-effectiveness | Cost-saving | Cost-saving | ICER: $22 per QALY gained | Cost-saving | Cost-saving | Cost-saving | Cost-saving | |
Standard vaccination campaign*** | Costs saved | $ 244,482,745 | $ 4,650,194,020 | $ 80,149,172 | $ 1,220,452,465 | $ 319,049,088 | $ 9,291,807,794 | $ 660,129,685 |
QALYs gained* | 579,592 | 1,101,496 | 108,161 | 541,621 | 41,203 | 1,519,802 | 639,047 | |
Deaths avoided | 67,159 | 129,451 | 13,293 | 57,972 | 4,099 | 165,805 | 71,047 | |
Cost-effectiveness | Cost-saving | Cost-saving | Cost-saving | Cost-saving | Cost-saving | Cost-saving | Cost-saving | |
Optimized vaccination campaign**** | Costs Saved | $ 329,514,258 | $ 4,488,290,446 | $ 102,289,321 | $ 1,358,560,340 | $ 440,842,304 | $ 11,123,858,434 | $ 739,338,504 |
QALYs gained* | 810,293 | 1,419,377 | 150,731 | 742,587 | 56,440 | 1,971,977 | 878,760 | |
Deaths avoided | 93,945 | 170,268 | 18,624 | 80,150 | 5,651 | 218,125 | 98,679 | |
Cost-effectiveness | Cost-saving | Cost-saving | Cost-saving | Cost-saving | Cost-saving | Cost-saving | Cost-saving |